Who is sponsoring NCT07075783?

NCT07075783 is sponsored by Hospital Universiti Sains Malaysia.

What drugs are being tested in NCT07075783?

Interventions in NCT07075783: MgSO4 plus Ropivacaine, Plain Ropivacaine.

What condition does NCT07075783 study?

NCT07075783 studies Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block.

Is NCT07075783 still recruiting?

NCT07075783 is currently completed. Last updated 20 July 2025.

Last reviewed 2025-07-20 · How we verify

NCT07075783

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial

Completed Phase 4 Last updated 20 July 2025

What this trial tests

Phase 4 trial testing MgSO4 plus Ropivacaine in Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block in 24 participants. Completed in 20 May 2025.

Timeline

3 October 2024

Primary endpoint
15 April 2025

20 May 2025

Quick facts

Lead sponsor	Hospital Universiti Sains Malaysia
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	24
Start date	3 October 2024
Primary completion	15 April 2025
Estimated completion	20 May 2025
Sites	1 location across Malaysia

Drugs / interventions tested

MgSO4 plus Ropivacaine — full drug profile →
Plain Ropivacaine — full drug profile →

Conditions studied

Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block — all drugs for Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block →

Sponsor

Hospital Universiti Sains Malaysia

Who can join

18 and older, any sex, with Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blinded controlled trial was conducted to evaluate the analgesic efficacy of MgSO4 as an adjuvant to ropivacaine in scalp blocks for craniotomy, focusing on its impact on hemodynamic parameters and intraoperative remifentanil consumption.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hospital Universiti Sains Malaysia trials

Trials by the same sponsor.

NCT07299552 — Effects of Vitamin D in Patients Undergoing Fixed Orthodontic Mechanotherapy · NA · not yet recruiting
NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT06889285 — Comparison of Safety and Efficacy Between PIEB and CEI for Labour Epidural Analgesia · Phase 4 · not yet recruiting
NCT06723249 — Stingless Bee Honey Augmentation in Major Depressive Disorders · NA · completed
NCT07472465 — Comparing Chitosan Sponge With Hydrocolloid as Dressing for Split-thickness Skin Graft Donor Site Wounds · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07075783 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universiti Sains Malaysia
Last refreshed: 20 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07075783.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing